Drugbank Logo

Search Results

Search for "Clofibrate" returned 7 results

Showing 1-7 out of 7
DrugBank ID Name Formula Weight
DB00636
DrugCard button for DB00636
Clofibrate C12H15ClO3 242.6990
Clofibrate Clofibrate is an antilipidemic agent similar to gemfibrozil. It acts to lower elevated serum lipids by reducing the very low-density lipoprotein fraction (S<sub>f</sub> 20-400) rich in ...
DB01241
DrugCard button for DB01241
Gemfibrozil C15H22O3 250.3334
... Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia. It acts to reduce ...
DB01308
DrugCard button for DB01308
Insulin-glargine C267H408N72O77S6 6050.9226
... The beta-blocker decreases the symptoms of hypoglycemia Clofibrate Clofibrate increases the effect of insulin Demeclocycline Tetracycline increases the risk of hypoglycemia Dexfenfluramine ...
DB00414
DrugCard button for DB00414
Acetohexamide C15H20N2O4S 324.3950
... Chloramphenicol The agent increases the effect of sulfonylurea Clofibrate The agent increases the effect of sulfonylurea Diazoxide Diazoxide / sulfonylurea:Antagonism of action Dicumarol The ...
DB00672
DrugCard button for DB00672
Chlorpropamide C10H13ClN2O3S 276.7400
... Chloramphenicol The agent increases the effect of sulfonylurea Clofibrate The agent increases the effect of sulfonylurea Diazoxide Diazoxyde/sulfonylurea: antagonism of action Dicumarol The ...
DB01120
DrugCard button for DB01120
Gliclazide C15H21N3O3S 323.4110
... Chloramphenicol The agent increases the effect of sulfonylurea Clofibrate The agent increases the effect of sulfonylurea Dicumarol The agent increases the effect of sulfonylurea Esmolol The ...
DB01016
DrugCard button for DB01016
Glibenclamide C23H28ClN3O5S 494.0040
... Chloramphenicol The agent increases the effect of sulfonylurea Clofibrate The agent increases the effect of sulfonylurea Cyclosporine The sulfonylurea increases the effect of cyclosporine ...
Showing 1-7 out of 7

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.